SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech gets GMP certification for new injectable facility

10 Jan 2025 Evaluate

Windlas Biotech has received Good Manufacturing Practices (GMP) certification for its new State-of-the-Art Injectable facility from the Food Safety & Drugs Administration Authority of Uttarakhand, following the inspection in December 2024. The certification states, that the firm is following the Good Manufacturing Practices as per World Health Organization (WHO) TRS Guidelines.

The state-of-the-art facility has been designed with cutting-edge technology and advanced infrastructure to ensure the efficient and safe production of sterile injectable formulations. Equipped with automated systems, robust quality control mechanisms, and eco-friendly processes, the facility exemplifies its strategic focus on operational excellence and sustainability.

With this new GMP-certified injectable facility, all five of Windlas Biotech Manufacturing plants are complying to this standard and it is well poised to expand its product portfolio offerings in the CDMO space.

Windlas Biotech provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. 

Windlas Biotech Share Price

860.00 -11.75 (-1.35%)
17-Apr-2026 13:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.85
Dr. Reddys Lab 1230.00
Cipla 1235.00
Zydus Lifesciences 944.40
Lupin 2307.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×